Henry Dao
By this expert
Crying Wolf: Why Negotiating Lower Drug Prices Will Not Harm Pharmaceutical Innovation
Increasing evidence that the IRA is probably not harming pharmaceutical innovation.
Implications of the Inflation Reduction Act for the Biotechnology Industry
Sensitivity of investment and valuation to drug price indices and market conditions